Characterization and outcomes in patients with mogamulizumab-associated skin reactions in the MAVORIC trial.

Musiek, Amy C M; Whittaker, Sean; Horowitz, Steven M; Bagot, Martine; Huen, Auris; Fisher, David C; Haun, Paul; Vermeer, Maarten H; Ito, Takahiro; Dwyer, Karen; Herr, Fiona; Kim, Youn H

Musiek, Amy C M; Whittaker, Sean; Horowitz, Steven M; Bagot, Martine; Huen, Auris; Fisher, David C; Haun, Paul; Vermeer, Maarten H; Ito, Takahiro; Dwyer, Karen; Herr, Fiona; Kim, Youn H.

Afiliação

Musiek ACM; Washington University, St. Louis, MO, United States.
Whittaker S; King's College London, Strand, London, United Kingdom.
Horowitz SM; Memorial Sloan-Kettering Cancer Center, New York, NY, United States.
Bagot M; Hôpital Saint Louis, APHP, Inserm U976, Université de Paris, Paris, France.
Huen A; MD Anderson Cancer Center, Houston, TX, United States.
Fisher DC; Dana-Farber Cancer Institute, Boston, MA, United States.
Haun P; University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, United States.
Vermeer MH; Leiden University Medical Center, Leiden, Netherlands.
Ito T; Kyowa Kirin Pharmaceutical Development, Inc., Princeton, NJ, United States.
Dwyer K; Kyowa Kirin Pharmaceutical Development, Inc., Princeton, NJ, United States.
Herr F; Kyowa Kirin, Inc., Bedminster, NJ, United States.
Kim YH; Stanford University, Stanford, CA, United States.